Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
99.9M
-
Shares change
-
+3.86M
-
Total reported value, excl. options
-
$4.83B
-
Value change
-
+$200M
-
Put/Call ratio
-
0.57
-
Number of buys
-
118
-
Number of sells
-
-58
-
Price
-
$48.38
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q2 2020
212 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q2 2020.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99.9M shares
of 152M outstanding shares and own 65.79% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (33.5M shares), Matrix Capital Management Company, LP (15.1M shares), VANGUARD GROUP INC (5.64M shares), BlackRock Inc. (5.61M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.72M shares), GILDER GAGNON HOWE & CO LLC (2.46M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.24M shares), Artisan Partners Limited Partnership (2.07M shares), Neuberger Berman Group LLC (1.72M shares), and Senator Investment Group LP (1.65M shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.